Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.
about
Targeting improves MSC treatment of inflammatory bowel diseaseCell therapy for myocardial infarction: Special deliveryInfluence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies?In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear MedicineMesenchymal Stem Cell-Mediated Effects of Tumor Support or SuppressionMesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technologyCardiac regeneration therapy: connections to cardiac physiologyMesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac diseaseGene and cell therapies for the failing heart to prevent sudden arrhythmic deathTherapeutic potential of Pnmt+ primer cells for neuro/myocardial regenerationUse of mesenchymal stem cells for therapy of cardiac diseaseCurrent stem cell delivery methods for myocardial repairStem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regenerationEngineering mesenchymal stem cells for regenerative medicine and drug deliveryIntrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysisRapidly self-renewing human multipotent marrow stromal cells (hMSC) express sialyl Lewis X and actively adhere to arterial endothelium in a chick embryo model systemMesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shearCell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffoldBiodistribution, migration and homing of systemically applied mesenchymal stem/stromal cellsMesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterologyImmunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?The endometrium as a source of mesenchymal stem cells for regenerative medicineDetection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomographyNew Delivery Systems of Stem Cells for Vascular Regeneration in IschemiaUltrasound-Targeted Microbubble Destruction Improves the Migration and Homing of Mesenchymal Stem Cells after Myocardial Infarction by Upregulating SDF-1/CXCR4: A Pilot Study.Seeing stem cells at work in vivo.Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarctionTargeting mesenchymal stem cells to activated endothelial cells.Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic miceMultimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing.Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles.Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kineticsA prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivoMurine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human.Cardiac repair with adult bone marrow-derived cells: the clinical evidence.TNF-alpha is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice.Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal healthThe effect of adipose tissue-derived stem cells in a middle cerebral artery occlusion stroke model depends on their engraftment rate
P2860
Q24601626-B63ADD82-7394-493D-A7EC-F13A07C2ED1EQ24644812-8FD30D25-16BD-4EA7-9F20-C36DCC4F8302Q24812198-C0BF3194-1A93-42AE-8A7A-3902E47B7A13Q26765900-DC6271BE-E96B-4935-B574-F7D88D639DBFQ26773413-6628260C-3C03-46A1-A6FF-24C913E2CBA4Q26796475-6E87DB62-4234-4233-B57E-4254B6E1F143Q26821929-1DADC63A-3214-491B-BC07-CE3E6641697EQ26822619-B6CEFC9E-C41B-44E1-A42E-A2AE0452ECA3Q26865070-C45D5092-A4F2-49D0-903C-7D0518210614Q26865425-D88198C6-5638-466F-8AC8-B9A3A67A77D3Q27002374-0FE9A71D-CF4C-44F4-ABF6-50B723245E48Q27003127-C6D25977-5C21-4031-8D15-BE24B409409CQ27004753-93A375CF-134E-4170-8532-222F4D2A6DC3Q27026285-0ABA2937-CC11-40C8-B705-FC8D2E7E2C37Q27026414-51F36678-7F16-4CD2-8F62-A1D009754205Q27310275-86FB6B67-D5D8-4B48-8FA7-F6ED6A640585Q27314509-2C4F689C-BFDC-4EAB-9B96-175A91986A61Q27317423-299CE5CB-93BA-4711-8D33-43A1E1E4457BQ27347330-410DF0E4-709B-40FC-A56E-BA4ADF1C8E5BQ28069791-DB0CB81A-8EB6-44D6-8BFD-5B30174855FAQ28077427-7C5757C1-3294-4ABB-97AB-743630A0931AQ28084829-34D18427-3DE5-406B-B626-37289F1CB908Q28087579-87698E88-4EF7-4A6A-A793-07EB6F0566A1Q30355871-D71FCD90-F0D1-4104-92EB-9EACA1AA2AF0Q30361288-42ED0BDC-C8B1-4B46-85F7-87833C834F43Q30409340-2CE71879-C17A-4A41-9B09-ABAE7A114B3FQ30420004-2C107619-A919-4BC4-80F8-40D29AF4DC4CQ30477220-5D1984FD-388B-44C7-A183-2DC0EA4201EDQ30488087-DE579FE7-3D84-46F1-82B6-3D3D69FFD980Q30503408-91588C8A-79C5-4ADD-83DC-BB22F85E92B9Q30530998-23925803-30AD-4FBD-8E1C-75FEB9C53531Q30532793-1228503C-B8AA-4173-AD59-5C2806E4545CQ30541132-52ED3DDB-16E8-4FC6-8EB5-560C64C66F02Q30541785-21881513-4CEE-436E-8EEA-C9FDD2B3CFDAQ33283525-4DBA683B-5A25-4AC2-B33B-A94509CAB5F4Q33359534-0BFE06B7-60C5-4E0A-9ACA-4123E77CF65EQ33406980-033B69D1-70F3-4FD8-9E25-6D5450CE6E02Q33408808-C27F64C1-B882-4422-AF20-18EFAC53C547Q33576818-2CBD0C59-7A32-4DBF-8CA8-B71FFEA07F2FQ33608949-DAC49D4A-6363-4CA7-A017-EE2C965CF8BA
P2860
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Systemic delivery of bone marr ...... ration, and body distribution.
@en
Systemic delivery of bone marr ...... ration, and body distribution.
@nl
type
label
Systemic delivery of bone marr ...... ration, and body distribution.
@en
Systemic delivery of bone marr ...... ration, and body distribution.
@nl
prefLabel
Systemic delivery of bone marr ...... ration, and body distribution.
@en
Systemic delivery of bone marr ...... ration, and body distribution.
@nl
P2093
P1433
P1476
Systemic delivery of bone marr ...... gration, and body distribution
@en
P2093
Ariel Tessone
Dov Zipori
Esther Guetta
Israel M Barbash
Jack Baron
Jonathan Leor
Laurence H Kedes
Liron Miller
Micha S Feinberg
Pierre Chouraqui
P304
P356
10.1161/01.CIR.0000084828.50310.6A
P407
P577
2003-08-04T00:00:00Z